Asia Business News | Thursday, October 16, 2008
RSS 2.0  
Arana Therapeutics Excellence In Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics



About Arana Therapeutics Limited

Undertake research, development, production, formulation and marketing of peptides, and related products for the the pharmaceutical, veterinary and agricultural industries.

About ARANA THERAPEUTICS

Peptech and Evogenix merged on the 28th August 07. The two companies have now been renamed Arana Therapeutics and listed on the Australian Stock Exchange under the equity code of ASX:AAH.



 
   ARANA THERAPEUTICS LIMITED  
   ARANA THERAPEUTICS  
   ABN NEWSWIRE